Biobetter biotechs emerge as preclinical services clients
Biotechs set up to take an existing biologic, improve it and license the resulting biobetter are an emerging client for preclinical service providers.
Biotechs set up to take an existing biologic, improve it and license the resulting biobetter are an emerging client for preclinical service providers.
Californian Bioreactor manufacturer, PBS Biotech, has launched its new PBS 3 single-use bioreactor system for the development of biological therapeutics, vaccines and biosimilars.